K. Shimizu et al. / Bioorg. Med. Chem. Lett. 16 (2006) 3323–3329
3329
van de Kerkhof, P. C.; Hanssen, L. I.; Tegner, E.; Burg,
G.; Talbot, D.; Chu, A. J. Am. Acad. Dermatol. 2003, 48,
48.
Dr. Tadakatsu Takahashi, Mr. Toru Esaki, Dr. Masaki
Ishigai, Dr. Kosuke Kawashima, Mr. Shohtaro Takada,
Mr. Nobuo Koike, Mr. Kazuo Tokuda, Dr. Eigoro
Murayama, and Dr. Noboru Kubodera in Chugai Phar-
maceutical Co., Ltd, for their advice and encouragement.
We acknowledge Ms. Frances Ford in Chugai for her use-
ful advice in the preparation and language editing of this
paper.
15. Bourke, J. F.; Berth-Jones, J.; Iqbal, S. J.; Hutchinson, P.
E. Br. J. Dermatol. 1993, 129, 74.
16. Shimizu, K.; Kawase, A.; Haneishi, T.; Kato, Y.; Kobay-
ashi, T.; Sekiguchi, N.; Yamamoto, T.; Ishigai, M.;
Tokuda, K.; Matsushita, T.; Shimaoka, S.; Morikawa,
K. Bioorg. Med. Chem 2006, 14, 1838.
17. Watanabe, H.; Hatakeyama, S.; Tazumi, K.; Takano, S.;
Masuda, S.; Okano, T.; Kobayashi, T.; Kubodera, N.
Chem. Pharm. Bull. 1996, 44, 2280.
18. Antedrug is a locally active synthetic derivative of a drug
undergoing biotransformations to readily excretable inac-
tive form upon entry in the systemic circulation thus
minimizing systemic side effects Lee, H. J.; Soliman, M. R.
Science 1982, 215, 989.
Supplementary data
Supplementary data associated with this article can be
19. It was also called as ‘soft drug.’ See Bodor, N. Med. Res.
Rev. 1984, 4, 449.
20. Kimura, T. Nippon Rinsho 1994, 52, 691.
21. Esvelt, R. P.; De Luca, H. F. Arch. Biochem. Biophys.
1981, 206, 403.
22. Kawase, A. JP Patent 10-231284, 1998.
23. Shimizu, H.; Shimizu, K.; Kubodera, N.; Mikami, T.;
Tsuzaki, K.; Suwa, H.; Harada, K.; Hiraide, A.; Shimizu,
M.; Koyama, K.; Ichikawa, Y.; Hirasawa, D.; Kito, Y.;
Kobayashi, M.; Kigawa, M.; Kato, M.; Kozono, T.;
Tanaka, H.; Tanabe, M.; Iguchi, M.; Yoshida, M. Org.
Process Res. Dev. 2005, 9, 278.
24. Kubodera, N. Yuki Gosei Kagaku Kyokaishi 2005, 63,
728.
25. Zhu, G.-D.; Okamura, W. H. Chem. Rev. 1995, 95,
1877.
26. Kubodera, N.; Miyamoto, K.; Ochi, K.; Matsunaga, I.
Chem. Pharm. Bull. 1986, 34, 2286.
27. Kubodera, N.; Miyamoto, K.; Watanabe, H.; Kato,
M.; Sasahara, K.; Ochi, K. J. Org. Chem. 1992, 57,
5019.
References and notes
1. Zheng, P. S.; Lavker, R. M.; Lehmann, P.; Kligman, A.
M. J. Invest. Dermatol. 1984, 82, 345.
2. DiStefano, V.; Nixon, J. E. Clin. Orthop. 1972, 87, 254.
3. Foldvari, F.; Vertes, B. Fulope Dermatol. 1962, 125, 93.
4. Kamm, J. J. J. Am. Acad. Dermatol. 1982, 6, 652.
5. Flechner, S. M. Urol. Clin. North Am. 1983, 10, 263.
6. Nyfors, A.; Poulsen, H. Acta Pathol. Microbiol. Scand.
[A] 1976, 84, 262.
7. Nyfors, A.; Poulsen, H. Acta Pathol. Microbiol. Scand.
[A] 1976, 84, 253.
8. Imokawa, S.; Colby, T. V.; Leslie, K. O.; Helmers, R. A.
Eur. Respir. J. 2000, 15, 373.
9. Tanaka, H.; Abe, E.; Miyaura, C.; Kuribayashi, T.; Konno,
K.; Nishii, Y.; Suda, T. Biochem. J. 1982, 204, 713.
10. Bouillon, R.; Okamura, W. H.; Norman, A. W. Endocr.
Rev. 1995, 16, 200.
11. Murayama, E.; Miyamoto, K.; Kubodera, N.; Mori, T.;
Matsunaga, I. Chem. Pharm. Bull. 1986, 34, 4410.
12. Morisaki, M.; Koizumi, N.; Ikekawa, N.; Takeshita, T.;
Ishimoto, S. J. Chem. Soc., Perkin Trans. 1 1975, 1421.
13. Binderup, L.; Bramm, E. Biochem. Pharmacol. 1988, 37,
889.
28. Nagpal, S.; Lu, J.; Boehm, M. F. Curr. Med. Chem. 2001,
8, 1661.
29. Lewis, D. F. V.; Dickins, M. Drug Metab. Rev. 2003,
35, 1.
30. Takeyama, K.; Masuhiro, Y.; Fuse, H.; Endoh, H.;
Murayama, A.; Kitanaka, S.; Suzawa, M.; Yanagisawa,
J.; Kato, S. Mol. Cell. Biol. 1999, 19, 1049.
14. Papp, K. A.; Guenther, L.; Boyden, B.; Larsen, F. G.;
Harvima, R. J.; Guilhou, J. J.; Kaufmann, R.; Rogers, S.;